Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078116 | SCV000109954 | benign | not specified | 2015-08-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000078116 | SCV000168034 | benign | not specified | 2013-05-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000202483 | SCV000358103 | benign | Carnitine palmitoyltransferase II deficiency | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics | RCV000711317 | SCV000841658 | benign | not provided | 2018-05-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000711317 | SCV001156717 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000202483 | SCV001733020 | benign | Carnitine palmitoyltransferase II deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533571 | SCV001750233 | benign | Carnitine palmitoyl transferase II deficiency, severe infantile form | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533572 | SCV001750234 | benign | Carnitine palmitoyl transferase II deficiency, neonatal form | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000711317 | SCV005284617 | benign | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000202483 | SCV000153653 | not provided | Carnitine palmitoyltransferase II deficiency | no assertion provided | literature only | ||
Natera, |
RCV000202483 | SCV001454237 | benign | Carnitine palmitoyltransferase II deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000078116 | SCV001744869 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078116 | SCV001958359 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003974955 | SCV004793413 | benign | CPT2-related disorder | 2019-06-06 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |